ID   PRP19_HUMAN             Reviewed;         504 AA.
AC   Q9UMS4;
DT   23-NOV-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   10-MAY-2017, entry version 156.
DE   RecName: Full=Pre-mRNA-processing factor 19 {ECO:0000305};
DE            EC=2.3.2.27 {ECO:0000269|PubMed:11435423};
DE   AltName: Full=Nuclear matrix protein 200 {ECO:0000303|PubMed:11082287};
DE   AltName: Full=PRP19/PSO4 homolog {ECO:0000303|PubMed:12960389};
DE            Short=hPso4 {ECO:0000303|PubMed:12960389};
DE   AltName: Full=RING-type E3 ubiquitin transferase PRP19 {ECO:0000305};
DE   AltName: Full=Senescence evasion factor {ECO:0000303|PubMed:16332694};
GN   Name=PRPF19 {ECO:0000312|HGNC:HGNC:17896};
GN   Synonyms=NMP200 {ECO:0000303|PubMed:11082287},
GN   PRP19 {ECO:0000303|PubMed:11435423},
GN   SNEV {ECO:0000303|PubMed:16332694};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 32-40; 100-115;
RP   179-187; 192-199 AND 334-342, FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND CHROMOSOMAL LOCATION.
RC   TISSUE=Cervix;
RX   PubMed=11082287; DOI=10.1006/excr.2000.5025;
RA   Gotzmann J., Gerner C., Meissner M., Holzmann K., Grimm R.,
RA   Mikulits W., Sauermann G.;
RT   "hNMP 200: a novel human common nuclear matrix protein combining
RT   structural and regulatory functions.";
RL   Exp. Cell Res. 261:166-179(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, INDUCTION,
RP   AND INTERACTION WITH DNTT.
RX   PubMed=12960389; DOI=10.1073/pnas.1631060100;
RA   Mahajan K.N., Mitchell B.S.;
RT   "Role of human Pso4 in mammalian DNA repair and association with
RT   terminal deoxynucleotidyl transferase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:10746-10751(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-27; 33-56; 77-93; 101-115; 193-206; 209-236;
RP   252-261 AND 266-303, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT
RP   SER-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RA   Bienvenut W.V., Waridel P., Quadroni M.;
RL   Submitted (MAR-2009) to UniProtKB.
RN   [5]
RP   PROTEIN SEQUENCE OF 2-27; 33-56; 63-93; 101-115; 193-206; 209-261;
RP   266-303; 344-375 AND 429-439, CLEAVAGE OF INITIATOR METHIONINE,
RP   ACETYLATION AT SER-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Ovarian carcinoma;
RA   Bienvenut W.V.;
RL   Submitted (JAN-2010) to UniProtKB.
RN   [6]
RP   PROTEIN SEQUENCE OF 32-40, AND TISSUE SPECIFICITY.
RC   TISSUE=Peripheral blood;
RX   PubMed=10404385;
RX   DOI=10.1002/(SICI)1097-4644(19990801)74:2<145::AID-JCB1>3.3.CO;2-R;
RA   Gerner C., Holzmann K., Meissner M., Gotzmann J., Grimm R.,
RA   Sauermann G.;
RT   "Reassembling proteins and chaperones in human nuclear matrix protein
RT   fractions.";
RL   J. Cell. Biochem. 74:145-151(1999).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=11435423; DOI=10.1074/jbc.M102755200;
RA   Hatakeyama S., Yada M., Matsumoto M., Ishida N., Nakayama K.I.;
RT   "U box proteins as a new family of ubiquitin-protein ligases.";
RL   J. Biol. Chem. 276:33111-33120(2001).
RN   [8]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=12429849; DOI=10.1091/mbc.E02-05-0271;
RA   Scherl A., Coute Y., Deon C., Calle A., Kindbeiter K., Sanchez J.-C.,
RA   Greco A., Hochstrasser D.F., Diaz J.-J.;
RT   "Functional proteomic analysis of human nucleolus.";
RL   Mol. Biol. Cell 13:4100-4109(2002).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE
RP   SPLICEOSOMAL C COMPLEX.
RX   PubMed=11991638; DOI=10.1017/S1355838202021088;
RA   Jurica M.S., Licklider L.J., Gygi S.P., Grigorieff N., Moore M.J.;
RT   "Purification and characterization of native spliceosomes suitable for
RT   three-dimensional structural analysis.";
RL   RNA 8:426-439(2002).
RN   [10]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=16332694; DOI=10.1093/nar/gki986;
RA   Grillari J., Ajuh P., Stadler G., Loescher M., Voglauer R., Ernst W.,
RA   Chusainow J., Eisenhaber F., Pokar M., Fortschegger K., Grey M.,
RA   Lamond A.I., Katinger H.;
RT   "SNEV is an evolutionarily conserved splicing factor whose
RT   oligomerization is necessary for spliceosome assembly.";
RL   Nucleic Acids Res. 33:6868-6883(2005).
RN   [11]
RP   INTERACTION WITH PSMB4, AND FUNCTION.
RX   PubMed=15660529; DOI=10.1042/BJ20041517;
RA   Loescher M., Fortschegger K., Ritter G., Wostry M., Voglauer R.,
RA   Schmid J.A., Watters S., Rivett A.J., Ajuh P., Lamond A.I.,
RA   Katinger H., Grillari J.;
RT   "Interaction of U-box E3 ligase SNEV with PSMB4, the beta7 subunit of
RT   the 20 S proteasome.";
RL   Biochem. J. 388:593-603(2005).
RN   [12]
RP   FUNCTION, AND IDENTIFICATION AS A COMPONENT OF THE PSO4 COMPLEX.
RX   PubMed=16223718; DOI=10.1074/jbc.M508453200;
RA   Zhang N., Kaur R., Lu X., Shen X., Li L., Legerski R.J.;
RT   "The Pso4 mRNA splicing and DNA repair complex interacts with WRN for
RT   processing of DNA interstrand cross-links.";
RL   J. Biol. Chem. 280:40559-40567(2005).
RN   [13]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=16388800; DOI=10.1016/j.yexcr.2005.11.025;
RA   Voglauer R., Chang M.W.-F., Dampier B., Wieser M., Baumann K.,
RA   Sterovsky T., Schreiber M., Katinger H., Grillari J.;
RT   "SNEV overexpression extends the life span of human endothelial
RT   cells.";
RL   Exp. Cell Res. 312:746-759(2006).
RN   [14]
RP   FUNCTION.
RX   PubMed=17349974; DOI=10.1016/j.bbrc.2007.02.134;
RA   Sihn C.R., Cho S.Y., Lee J.H., Lee T.R., Kim S.H.;
RT   "Mouse homologue of yeast Prp19 interacts with mouse SUG1, the
RT   regulatory subunit of 26S proteasome.";
RL   Biochem. Biophys. Res. Commun. 356:175-180(2007).
RN   [15]
RP   FUNCTION, AND IDENTIFICATION AS PART OF THE XAB2 COMPLEX.
RX   PubMed=17981804; DOI=10.1074/jbc.M706647200;
RA   Kuraoka I., Ito S., Wada T., Hayashida M., Lee L., Saijo M.,
RA   Nakatsu Y., Matsumoto M., Matsunaga T., Handa H., Qin J., Nakatani Y.,
RA   Tanaka K.;
RT   "Isolation of XAB2 complex involved in pre-mRNA splicing,
RT   transcription, and transcription-coupled repair.";
RL   J. Biol. Chem. 283:940-950(2008).
RN   [16]
RP   FUNCTION, INTERACTION WITH SETMAR, AND SUBCELLULAR LOCATION.
RX   PubMed=18263876; DOI=10.1074/jbc.M800150200;
RA   Beck B.D., Park S.J., Lee Y.J., Roman Y., Hromas R.A., Lee S.H.;
RT   "Human Pso4 is a metnase (SETMAR)-binding partner that regulates
RT   metnase function in DNA repair.";
RL   J. Biol. Chem. 283:9023-9030(2008).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [19]
RP   INTERACTION WITH APEX1, IDENTIFICATION BY MASS SPECTROMETRY, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=19188445; DOI=10.1128/MCB.01337-08;
RA   Vascotto C., Fantini D., Romanello M., Cesaratto L., Deganuto M.,
RA   Leonardi A., Radicella J.P., Kelley M.R., D'Ambrosio C., Scaloni A.,
RA   Quadrifoglio F., Tell G.;
RT   "APE1/Ref-1 interacts with NPM1 within nucleoli and plays a role in
RT   the rRNA quality control process.";
RL   Mol. Cell. Biol. 29:1834-1854(2009).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-122 AND LYS-261, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [21]
RP   FUNCTION, AND INTERACTION WITH PRPF3.
RX   PubMed=20595234; DOI=10.1101/gad.1925010;
RA   Song E.J., Werner S.L., Neubauer J., Stegmeier F., Aspden J., Rio D.,
RA   Harper J.W., Elledge S.J., Kirschner M.W., Rape M.;
RT   "The Prp19 complex and the Usp4Sart3 deubiquitinating enzyme control
RT   reversible ubiquitination at the spliceosome.";
RL   Genes Dev. 24:1434-1447(2010).
RN   [22]
RP   IDENTIFICATION AS A COMPONENT OF THE PRP19-CDC5L SPLICING COMPLEX,
RP   IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR LOCATION, AND
RP   INTERACTION WITH CDC5L; PLRG1 AND BCAS2.
RX   PubMed=20176811; DOI=10.1128/MCB.01505-09;
RA   Grote M., Wolf E., Will C.L., Lemm I., Agafonov D.E., Schomburg A.,
RA   Fischle W., Urlaub H., Luhrmann R.;
RT   "Molecular architecture of the human Prp19/CDC5L complex.";
RL   Mol. Cell. Biol. 30:2105-2119(2010).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [24]
RP   FUNCTION, AND INTERACTION WITH U2AF2.
RX   PubMed=21536736; DOI=10.1101/gad.2038011;
RA   David C.J., Boyne A.R., Millhouse S.R., Manley J.L.;
RT   "The RNA polymerase II C-terminal domain promotes splicing activation
RT   through recruitment of a U2AF65-Prp19 complex.";
RL   Genes Dev. 25:972-983(2011).
RN   [25]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [26]
RP   INTERACTION WITH CWC22 AND EIF4A3.
RX   PubMed=22961380; DOI=10.1038/nsmb.2380;
RA   Barbosa I., Haque N., Fiorini F., Barrandon C., Tomasetto C.,
RA   Blanchette M., Le Hir H.;
RT   "Human CWC22 escorts the helicase eIF4AIII to spliceosomes and
RT   promotes exon junction complex assembly.";
RL   Nat. Struct. Mol. Biol. 19:983-990(2012).
RN   [27]
RP   FUNCTION, INTERACTION WITH RPA1 AND RPA2, DOMAIN, AND MUTAGENESIS OF
RP   TYR-405.
RX   PubMed=24332808; DOI=10.1016/j.molcel.2013.11.002;
RA   Marechal A., Li J.M., Ji X.Y., Wu C.S., Yazinski S.A., Nguyen H.D.,
RA   Liu S., Jimenez A.E., Jin J., Zou L.;
RT   "PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and
RT   drives ATR activation via a ubiquitin-mediated circuitry.";
RL   Mol. Cell 53:235-246(2014).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (1.89 ANGSTROMS) OF 169-504.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of PRPF19 WD40 repeats.";
RL   Submitted (JUN-2013) to the PDB data bank.
RN   [29]
RP   INTERACTION WITH KNSTRN.
RX   PubMed=24718257; DOI=10.1371/journal.pone.0092712;
RA   Lu S., Wang R., Cai C., Liang J., Xu L., Miao S., Wang L., Song W.;
RT   "Small kinetochore associated protein (SKAP) promotes UV-induced cell
RT   apoptosis through negatively regulating pre-mRNA processing factor 19
RT   (Prp19).";
RL   PLoS ONE 9:E92712-E92712(2014).
CC   -!- FUNCTION: Ubiquitin-protein ligase which is a core component of
CC       several complexes mainly involved pre-mRNA splicing and DNA
CC       repair. Core component of the PRP19C/Prp19 complex/NTC/Nineteen
CC       complex which is part of the spliceosome and participates in its
CC       assembly, its remodeling and is required for its activity. During
CC       assembly of the spliceosome, mediates 'Lys-63'-linked
CC       polyubiquitination of the U4 spliceosomal protein PRPF3.
CC       Ubiquitination of PRPF3 allows its recognition by the U5 component
CC       PRPF8 and stabilizes the U4/U5/U6 tri-snRNP spliceosomal complex
CC       (PubMed:20595234). Recruited to RNA polymerase II C-terminal
CC       domain (CTD) and the pre-mRNA, it may also couple the
CC       transcriptional and spliceosomal machineries (PubMed:21536736).
CC       The XAB2 complex, which contains PRPF19, is also involved in pre-
CC       mRNA splicing, transcription and transcription-coupled repair
CC       (PubMed:17981804). Beside its role in pre-mRNA splicing PRPF19, as
CC       part of the PRP19-CDC5L complex, plays a role in the DNA damage
CC       response/DDR. It is recruited to the sites of DNA damage by the
CC       RPA complex where PRPF19 directly ubiquitinates RPA1 and RPA2.
CC       'Lys-63'-linked polyubiquitination of the RPA complex allows the
CC       recruitment of the ATR-ATRIP complex and the activation of ATR, a
CC       master regulator of the DNA damage response (PubMed:24332808). May
CC       also play a role in DNA double-strand break (DSB) repair by
CC       recruiting the repair factor SETMAR to altered DNA
CC       (PubMed:18263876). As part of the PSO4 complex may also be
CC       involved in the DNA interstrand cross-links/ICLs repair process
CC       (PubMed:16223718). In addition, may also mediate 'Lys-48'-linked
CC       polyubiquitination of substrates and play a role in proteasomal
CC       degradation (PubMed:11435423). May play a role in the biogenesis
CC       of lipid droplets (By similarity). May play a role in neural
CC       differentiation possibly through its function as part of the
CC       spliceosome (By similarity). {ECO:0000250|UniProtKB:Q99KP6,
CC       ECO:0000250|UniProtKB:Q9JMJ4, ECO:0000269|PubMed:11082287,
CC       ECO:0000269|PubMed:11435423, ECO:0000269|PubMed:12960389,
CC       ECO:0000269|PubMed:15660529, ECO:0000269|PubMed:16223718,
CC       ECO:0000269|PubMed:16332694, ECO:0000269|PubMed:16388800,
CC       ECO:0000269|PubMed:17349974, ECO:0000269|PubMed:18263876,
CC       ECO:0000269|PubMed:21536736, ECO:0000269|PubMed:24332808,
CC       ECO:0000303|PubMed:17981804, ECO:0000303|PubMed:20595234}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000269|PubMed:11435423}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000269|PubMed:11435423}.
CC   -!- SUBUNIT: Homotetramer. Component of the Prp19
CC       complex/PRP19C/Nineteen complex/NTC and related complexes
CC       described as PRP19-CDC5L splicing complex and PSO4 complex. A
CC       homotetramer of PRPF19, CDC5L, PLRG1 and BCAS2 constitute the core
CC       of those complexes. The interaction with CDC5L, PLRG1 and BCAS2 is
CC       direct within this core complex. At least three less stably
CC       associated proteins CTNNBL1, CWC15 and HSPA8 are found in the
CC       Prp19 complex. The Prp19 complex associates with the spliceosome
CC       during its assembly and remodeling recruiting additional proteins.
CC       Component of the XAB2 complex, a multimeric protein complex
CC       composed of XAB2, PRPF19, AQR, ZNF830, ISY1, and PPIE. Interacts
CC       with CWC22 and EIF4A3 in an RNA-independent manner. Interacts with
CC       RPA1 and RPA2; the PRP19-CDC5L complex is recruited to the sites
CC       of DNA repair where it interacts with the replication protein A
CC       complex (RPA). Interacts with SETMAR; required for SETMAR
CC       recruitment to site of DNA damage. Interacts with U2AF2; the
CC       interaction is direct and recruits the Prp19 complex to RNA
CC       polymerase II C-terminal domain (CTD) and the pre-mRNA. Interacts
CC       with PRPF3. Interacts with APEX1, DNTT and PSMB4. Interacts with
CC       PSMC5 (By similarity). Interacts with KNSTRN (PubMed:24718257).
CC       Interacts (via N-terminus) with CDC5L (By similarity).
CC       {ECO:0000250|UniProtKB:Q99KP6, ECO:0000250|UniProtKB:Q9JMJ4,
CC       ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:12960389,
CC       ECO:0000269|PubMed:15660529, ECO:0000269|PubMed:16223718,
CC       ECO:0000269|PubMed:16332694, ECO:0000269|PubMed:17981804,
CC       ECO:0000269|PubMed:18263876, ECO:0000269|PubMed:19188445,
CC       ECO:0000269|PubMed:20176811, ECO:0000269|PubMed:20595234,
CC       ECO:0000269|PubMed:21536736, ECO:0000269|PubMed:22961380,
CC       ECO:0000269|PubMed:24332808, ECO:0000269|PubMed:24718257}.
CC   -!- INTERACTION:
CC       O75934:BCAS2; NbExp=2; IntAct=EBI-395746, EBI-1050106;
CC       O60508:CDC40; NbExp=2; IntAct=EBI-395746, EBI-2557812;
CC       Q99459:CDC5L; NbExp=2; IntAct=EBI-395746, EBI-374880;
CC       Q6P2Q9:PRPF8; NbExp=2; IntAct=EBI-395746, EBI-538479;
CC       P98175:RBM10; NbExp=2; IntAct=EBI-395746, EBI-721525;
CC       P52756:RBM5; NbExp=8; IntAct=EBI-395746, EBI-714003;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11082287,
CC       ECO:0000269|PubMed:12429849, ECO:0000269|PubMed:19188445,
CC       ECO:0000269|PubMed:20176811}. Nucleus, nucleoplasm
CC       {ECO:0000269|PubMed:11082287}. Cytoplasm, cytoskeleton, spindle
CC       {ECO:0000269|PubMed:11082287}. Cytoplasm
CC       {ECO:0000269|PubMed:11435423}. Lipid droplet
CC       {ECO:0000250|UniProtKB:Q99KP6}. Note=Nucleoplasmic in interphase
CC       cells. Irregularly distributed in anaphase cells. In prophase
CC       cells, uniformly distributed, but not associated with condensing
CC       chromosomes. Found in extrachromosomal regions in metaphase cells.
CC       Mainly localized to the mitotic spindle apparatus when chromosomes
CC       segregate during anaphase. When nuclei reform during late
CC       telophase, uniformly distributed in daughter cells and displays no
CC       preferred association with decondensing chromatin. Recruited on
CC       damaged DNA at sites of double-strand break.
CC       {ECO:0000269|PubMed:11082287, ECO:0000269|PubMed:18263876}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Weakly expressed in senescent
CC       cells of different tissue origins. Highly expressed in tumor cell
CC       lines. {ECO:0000269|PubMed:10404385, ECO:0000269|PubMed:11082287,
CC       ECO:0000269|PubMed:11435423, ECO:0000269|PubMed:12960389,
CC       ECO:0000269|PubMed:16388800}.
CC   -!- INDUCTION: By gamma irradiation and chemical mutagens but not by
CC       UV irradiation. {ECO:0000269|PubMed:12960389}.
CC   -!- DOMAIN: The 7 WD repeats are necessary and sufficient to support
CC       interaction with the RPA complex. {ECO:0000269|PubMed:24332808}.
CC   -!- SIMILARITY: Belongs to the WD repeat PRP19 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ131186; CAB51857.1; -; mRNA.
DR   EMBL; BC008719; AAH08719.1; -; mRNA.
DR   EMBL; BC018665; AAH18665.1; -; mRNA.
DR   EMBL; BC018698; AAH18698.1; -; mRNA.
DR   CCDS; CCDS7995.1; -.
DR   RefSeq; NP_055317.1; NM_014502.4.
DR   UniGene; Hs.502705; -.
DR   PDB; 4LG8; X-ray; 1.89 A; A=169-504.
DR   PDB; 5MQF; EM; 5.90 A; G/H/I/J=1-504.
DR   PDBsum; 4LG8; -.
DR   PDBsum; 5MQF; -.
DR   ProteinModelPortal; Q9UMS4; -.
DR   SMR; Q9UMS4; -.
DR   BioGrid; 118151; 173.
DR   DIP; DIP-32978N; -.
DR   IntAct; Q9UMS4; 42.
DR   MINT; MINT-1454442; -.
DR   STRING; 9606.ENSP00000227524; -.
DR   iPTMnet; Q9UMS4; -.
DR   PhosphoSitePlus; Q9UMS4; -.
DR   SwissPalm; Q9UMS4; -.
DR   BioMuta; PRPF19; -.
DR   DMDM; 55976619; -.
DR   REPRODUCTION-2DPAGE; IPI00004968; -.
DR   SWISS-2DPAGE; Q9UMS4; -.
DR   EPD; Q9UMS4; -.
DR   MaxQB; Q9UMS4; -.
DR   PaxDb; Q9UMS4; -.
DR   PeptideAtlas; Q9UMS4; -.
DR   PRIDE; Q9UMS4; -.
DR   DNASU; 27339; -.
DR   Ensembl; ENST00000227524; ENSP00000227524; ENSG00000110107.
DR   GeneID; 27339; -.
DR   KEGG; hsa:27339; -.
DR   UCSC; uc001nqf.4; human.
DR   CTD; 27339; -.
DR   DisGeNET; 27339; -.
DR   GeneCards; PRPF19; -.
DR   HGNC; HGNC:17896; PRPF19.
DR   HPA; CAB012448; -.
DR   HPA; HPA038051; -.
DR   HPA; HPA059070; -.
DR   MIM; 608330; gene.
DR   neXtProt; NX_Q9UMS4; -.
DR   OpenTargets; ENSG00000110107; -.
DR   PharmGKB; PA134941355; -.
DR   eggNOG; KOG0289; Eukaryota.
DR   eggNOG; ENOG410XPQV; LUCA.
DR   GeneTree; ENSGT00860000133707; -.
DR   HOGENOM; HOG000177308; -.
DR   HOVERGEN; HBG053697; -.
DR   InParanoid; Q9UMS4; -.
DR   KO; K10599; -.
DR   OMA; SEDQYWA; -.
DR   OrthoDB; EOG091G05AH; -.
DR   PhylomeDB; Q9UMS4; -.
DR   TreeFam; TF105919; -.
DR   Reactome; R-HSA-6781823; Formation of TC-NER Pre-Incision Complex.
DR   Reactome; R-HSA-6781827; Transcription-Coupled Nucleotide Excision Repair (TC-NER).
DR   Reactome; R-HSA-6782135; Dual incision in TC-NER.
DR   Reactome; R-HSA-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   SignaLink; Q9UMS4; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; PRPF19; human.
DR   GeneWiki; PRPF19; -.
DR   GenomeRNAi; 27339; -.
DR   PRO; PR:Q9UMS4; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000110107; -.
DR   CleanEx; HS_PRPF19; -.
DR   ExpressionAtlas; Q9UMS4; baseline and differential.
DR   Genevisible; Q9UMS4; HS.
DR   GO; GO:0071013; C:catalytic step 2 spliceosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005811; C:lipid particle; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000974; C:Prp19 complex; IDA:UniProtKB.
DR   GO; GO:0035861; C:site of double-strand break; IDA:UniProtKB.
DR   GO; GO:0005819; C:spindle; IEA:UniProtKB-SubCell.
DR   GO; GO:0071006; C:U2-type catalytic step 1 spliceosome; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:BHF-UCL.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:MGI.
DR   GO; GO:0034450; F:ubiquitin-ubiquitin ligase activity; IDA:MGI.
DR   GO; GO:0034613; P:cellular protein localization; IMP:UniProtKB.
DR   GO; GO:0006303; P:double-strand break repair via nonhomologous end joining; IMP:UniProtKB.
DR   GO; GO:0000349; P:generation of catalytic spliceosome for first transesterification step; IBA:GO_Central.
DR   GO; GO:0001833; P:inner cell mass cell proliferation; IEA:Ensembl.
DR   GO; GO:0008610; P:lipid biosynthetic process; IEA:Ensembl.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IDA:UniProtKB.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0048711; P:positive regulation of astrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0048026; P:positive regulation of mRNA splicing, via spliceosome; IEA:Ensembl.
DR   GO; GO:0010498; P:proteasomal protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0070534; P:protein K63-linked ubiquitination; IMP:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; IDA:MGI.
DR   GO; GO:0072422; P:signal transduction involved in DNA damage checkpoint; IMP:UniProtKB.
DR   GO; GO:0000245; P:spliceosomal complex assembly; IMP:BHF-UCL.
DR   GO; GO:0000244; P:spliceosomal tri-snRNP complex assembly; IDA:UniProtKB.
DR   GO; GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome.
DR   Gene3D; 2.130.10.10; -; 2.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR020472; G-protein_beta_WD-40_rep.
DR   InterPro; IPR013915; Pre-mRNA_splic_Prp19.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   InterPro; IPR003613; Ubox_domain.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF08606; Prp19; 1.
DR   Pfam; PF04564; U-box; 1.
DR   Pfam; PF00400; WD40; 5.
DR   PRINTS; PR00320; GPROTEINBRPT.
DR   SMART; SM00504; Ubox; 1.
DR   SMART; SM00320; WD40; 7.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS51698; U_BOX; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 1.
DR   PROSITE; PS50082; WD_REPEATS_2; 4.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; DNA damage; DNA repair; Lipid droplet;
KW   mRNA processing; mRNA splicing; Nucleus; Reference proteome; Repeat;
KW   Spliceosome; Transferase; Ubl conjugation pathway; WD repeat.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000269|Ref.4, ECO:0000269|Ref.5}.
FT   CHAIN         2    504       Pre-mRNA-processing factor 19.
FT                                /FTId=PRO_0000051145.
FT   DOMAIN        2     73       U-box.
FT   REPEAT      219    259       WD 1.
FT   REPEAT      262    301       WD 2.
FT   REPEAT      304    345       WD 3.
FT   REPEAT      348    387       WD 4.
FT   REPEAT      390    429       WD 5.
FT   REPEAT      433    472       WD 6.
FT   REPEAT      473    503       WD 7.
FT   REGION       68    223       May mediate interaction with PSMC5.
FT                                {ECO:0000250|UniProtKB:Q99KP6}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000269|Ref.4, ECO:0000269|Ref.5}.
FT   MOD_RES     122    122       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     179    179       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q99KP6}.
FT   MOD_RES     244    244       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q99KP6}.
FT   MOD_RES     261    261       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MUTAGEN     405    405       Y->A: Loss of interaction with the RPA
FT                                complex and loss of recruitment to sites
FT                                of DNA damage.
FT                                {ECO:0000269|PubMed:24332808}.
FT   HELIX       201    204       {ECO:0000244|PDB:4LG8}.
FT   STRAND      208    213       {ECO:0000244|PDB:4LG8}.
FT   STRAND      219    221       {ECO:0000244|PDB:4LG8}.
FT   STRAND      224    230       {ECO:0000244|PDB:4LG8}.
FT   STRAND      233    241       {ECO:0000244|PDB:4LG8}.
FT   STRAND      246    250       {ECO:0000244|PDB:4LG8}.
FT   TURN        251    254       {ECO:0000244|PDB:4LG8}.
FT   STRAND      255    260       {ECO:0000244|PDB:4LG8}.
FT   STRAND      269    272       {ECO:0000244|PDB:4LG8}.
FT   STRAND      276    282       {ECO:0000244|PDB:4LG8}.
FT   STRAND      288    292       {ECO:0000244|PDB:4LG8}.
FT   TURN        293    296       {ECO:0000244|PDB:4LG8}.
FT   STRAND      297    302       {ECO:0000244|PDB:4LG8}.
FT   STRAND      309    314       {ECO:0000244|PDB:4LG8}.
FT   STRAND      318    325       {ECO:0000244|PDB:4LG8}.
FT   STRAND      328    334       {ECO:0000244|PDB:4LG8}.
FT   TURN        335    337       {ECO:0000244|PDB:4LG8}.
FT   STRAND      340    345       {ECO:0000244|PDB:4LG8}.
FT   TURN        347    349       {ECO:0000244|PDB:4LG8}.
FT   STRAND      353    358       {ECO:0000244|PDB:4LG8}.
FT   STRAND      362    369       {ECO:0000244|PDB:4LG8}.
FT   STRAND      374    378       {ECO:0000244|PDB:4LG8}.
FT   TURN        379    382       {ECO:0000244|PDB:4LG8}.
FT   STRAND      383    388       {ECO:0000244|PDB:4LG8}.
FT   STRAND      395    400       {ECO:0000244|PDB:4LG8}.
FT   STRAND      404    411       {ECO:0000244|PDB:4LG8}.
FT   STRAND      414    420       {ECO:0000244|PDB:4LG8}.
FT   TURN        421    424       {ECO:0000244|PDB:4LG8}.
FT   STRAND      425    431       {ECO:0000244|PDB:4LG8}.
FT   STRAND      438    443       {ECO:0000244|PDB:4LG8}.
FT   STRAND      447    461       {ECO:0000244|PDB:4LG8}.
FT   TURN        462    465       {ECO:0000244|PDB:4LG8}.
FT   STRAND      466    471       {ECO:0000244|PDB:4LG8}.
FT   STRAND      474    476       {ECO:0000244|PDB:4LG8}.
FT   STRAND      478    483       {ECO:0000244|PDB:4LG8}.
FT   HELIX       485    487       {ECO:0000244|PDB:4LG8}.
FT   STRAND      490    494       {ECO:0000244|PDB:4LG8}.
FT   STRAND      499    503       {ECO:0000244|PDB:4LG8}.
SQ   SEQUENCE   504 AA;  55181 MW;  B34C37496E8AA032 CRC64;
     MSLICSISNE VPEHPCVSPV SNHVYERRLI EKYIAENGTD PINNQPLSEE QLIDIKVAHP
     IRPKPPSATS IPAILKALQD EWDAVMLHSF TLRQQLQTTR QELSHALYQH DAACRVIARL
     TKEVTAAREA LATLKPQAGL IVPQAVPSSQ PSVVGAGEPM DLGELVGMTP EIIQKLQDKA
     TVLTTERKKR GKTVPEELVK PEELSKYRQV ASHVGLHSAS IPGILALDLC PSDTNKILTG
     GADKNVVVFD KSSEQILATL KGHTKKVTSV VFHPSQDLVF SASPDATIRI WSVPNASCVQ
     VVRAHESAVT GLSLHATGDY LLSSSDDQYW AFSDIQTGRV LTKVTDETSG CSLTCAQFHP
     DGLIFGTGTM DSQIKIWDLK ERTNVANFPG HSGPITSIAF SENGYYLATA ADDSSVKLWD
     LRKLKNFKTL QLDNNFEVKS LIFDQSGTYL ALGGTDVQIY ICKQWTEILH FTEHSGLTTG
     VAFGHHAKFI ASTGMDRSLK FYSL
//
